Menu
Back to User profile » Professor David Price
Papers published by Professor David Price:
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis
Menzies-Gow AN, Tran TN, Stanley B, Carter VA, Smolen JS, Bourdin A, Fitzgerald JM, Raine T, Chapaneri J, Emmanuel B, Jackson DJ, Price DB
Pragmatic and Observational Research 2024, 15:53-64
Published Date: 15 March 2024
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS
Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G
Pragmatic and Observational Research 2024, 15:1-16
Published Date: 20 January 2024
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
Tse G, Emmanuel B, Ariti C, Bafadhel M, Papi A, Carter V, Zhou J, Skinner D, Xu X, Müllerová H, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2565-2580
Published Date: 15 November 2023
Adult Severe Asthma Registries: A Global and Growing Inventory
Cushen B, Koh MS, Tran TN, Martin N, Murray R, Uthaman T, Goh CYY, Vella R, Eleangovan N, Bulathsinhala L, Maspero JF, Peters MJ, Schleich F, Pitrez P, Christoff G, Sadatsafavi M, Torres-Duque CA, Porsbjerg C, Altraja A, Lehtimäki L, Bourdin A, Taube C, Papadopoulos NG, Zsuzsanna C, Björnsdóttir U, Salvi S, Heffler E, Iwanaga T, al-Ahmad M, Larenas-Linnemann D, van Boven JF, Aarli BB, Kuna P, Loureiro CC, Al-lehebi R, Lee JH, Marina N, Bjermer L, Sheu CC, Mahboub B, Busby J, Menzies-Gow A, Wang E, Price DB
Pragmatic and Observational Research 2023, 14:127-147
Published Date: 20 October 2023
Data-Resource Profile: United Kingdom Optimum Patient Care Research Database
Lynam A, Curtis C, Stanley B, Heatley H, Worthington C, Roberts EJ, Price C, Carter V, Dennis J, McGovern A, Price D
Pragmatic and Observational Research 2023, 14:39-49
Published Date: 27 April 2023
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
Chen W, Sadatsafavi M, Tran TN, Murray RB, Wong CBN, Ali N, Ariti C, Garcia Gil E, Newell A, Alacqua M, Al-Ahmad M, Altraja A, Al-Lehebi R, Bhutani M, Bjermer L, Bjerrum AS, Bourdin A, Bulathsinhala L, von Bülow A, Busby J, Canonica GW, Carter V, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Yoo KH, Heaney LG, Heffler E, Hew M, Hilberg O, Hoyte F, Iwanaga T, Jackson DJ, Jones RC, Koh MS, Kuna P, Larenas-Linnemann D, Lehmann S, Lehtimäki LA, Lyu J, Mahboub B, Maspero J, Menzies-Gow AN, Sirena C, Papadopoulos N, Papaioannou AI, Pérez de Llano L, Perng DW, Peters M, Pfeffer PE, Porsbjerg CM, Popov TA, Rhee CK, Salvi S, Taillé C, Taube C, Torres-Duque CA, Ulrik CS, Ra SW, Wang E, Wechsler ME, Price DB
Journal of Asthma and Allergy 2022, 15:1491-1510
Published Date: 21 October 2022
Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs
Leving MT, van Boven JFM, Bosnic-Anticevich SZ, van Cooten J, Correia de Sousa J, Cvetkovski B, Dekhuijzen R, Dijk L, García Pardo M, Gardev A, Gawlik R, van der Ham I, Hartgers-Gubbels ES, Janse Y, Lavorini F, Maricoto T, Meijer J, Metz B, Price DB, Roman-Rodríguez M, Schuttel K, Stoker N, Tsiligianni I, Usmani OS, Kocks JH
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2401-2415
Published Date: 25 September 2022
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
Chen S, Miravitlles M, Rhee CK, Pavord ID, Jones R, Carter V, Emmanuel B, Alacqua M, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2187-2200
Published Date: 9 September 2022
A Pragmatic Primary Practice Approach to Using Specific IgE in Allergy Testing in Asthma Diagnosis, Management, and Referral
Demoly P, Liu AH, Rodriguez del Rio P, Pedersen S, Casale TB, Price D
Journal of Asthma and Allergy 2022, 15:1069-1080
Published Date: 16 August 2022
Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse Effects
Hancock KL, Bosnic-Anticevich S, Blakey JD, Hew M, Chung LP, Cvetkovski B, Claxton S, Del Fante P, Denton E, Doan J, Ranasinghe K, Morgan L, Sharma A, Smith PK, Stewart D, Thompson PJ, Wiseman R, Upham JW, Yan KY, Carter V, Dhillon K, Heraud F, Le T, Vella R, Price D
Pragmatic and Observational Research 2022, 13:43-58
Published Date: 5 July 2022
Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry
Fox C, Pace W, Brandt E, Carter V, Chang KL, Edwards C, Evans A, Gaona G, Han MK, Kaplan A, Kent R, Kocks JWH, Kruszyk M, Le Lievre Chantal, LiVoti TM, Mahle C, Make B, Ratigan A, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB
Pragmatic and Observational Research 2022, 13:17-31
Published Date: 29 April 2022
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
Miravitlles M, Verhamme K, Calverley PMA, Dreher M, Bayer V, Gardev A, de la Hoz A, Wedzicha J, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:545-558
Published Date: 11 March 2022
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:489-490
Published Date: 7 March 2022
CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients
Alves L, Pullen R, Hurst JR, Miravitlles M, Carter V, Chen R, Couper A, Dransfield M, Evans A, Hardjojo A, Jones D, Jones R, Kerr M, Kostikas K, Marshall J, Martinez F, Melle MV, Murray R, Muro S, Nordon C, Pollack M, Price C, Sharma A, Singh D, Winders T, Price DB
Patient Related Outcome Measures 2022, 13:53-68
Published Date: 23 February 2022
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:355-370
Published Date: 15 February 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
Menzies-Gow AN, McBrien C, Unni B, Porsbjerg CM, Al-Ahmad M, Ambrose CS, Dahl Assing K, von Bülow A, Busby J, Cosio BG, FitzGerald JM, Garcia Gil E, Hansen S, Heaney LG, Hew M, Jackson DJ, Kallieri M, Loukides S, Lugogo NL, Papaioannou AI, Larenas-Linnemann D, Moore WC, Perez-de-Llano LA, Rasmussen LM, Schmid JM, Siddiqui S, Alacqua M, Tran TN, Suppli Ulrik C, Upham JW, Wang E, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Murray RB, Price CA, Price DB
Journal of Asthma and Allergy 2022, 15:63-78
Published Date: 13 January 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:79-92
Published Date: 6 January 2022
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care
Busby J, Price D, Al-Lehebi R, Bosnic-Anticevich S, van Boven JFM, Emmanuel B, FitzGerald JM, Gaga M, Hansen S, Hew M, Iwanaga T, Larenas Linnemann D, Mahboub B, Mitchell P, Morrone D, Pham J, Porsbjerg C, Roche N, Wang E, Eleangovan N, Heaney LG
Journal of Asthma and Allergy 2021, 14:1375-1388
Published Date: 10 November 2021
Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma
Price D, Menzies-Gow A, Bachert C, Canonica GW, Kocks J, Khan AH, Ye F, Rowe PJ, Lu Y, Kamat S, Carter V, Voorham J
Journal of Asthma and Allergy 2021, 14:1173-1183
Published Date: 29 September 2021
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care
Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2301-2322
Published Date: 12 August 2021
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients
Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D
Pragmatic and Observational Research 2021, 12:93-104
Published Date: 11 August 2021
High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma
Baron AJ, Flokstra-de Blok BM, Kerstjens HAM, Koopmans-Klein G, Price DB, Sellink AA, Tsiligianni I, Kocks JWH
Journal of Asthma and Allergy 2021, 14:851-861
Published Date: 12 July 2021
Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
Tran TN, Kerkhof M, Carter V, Price DB
Journal of Asthma and Allergy 2021, 14:727-742
Published Date: 25 June 2021
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes
Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin DMG, Pinnock H, Chalmers JD, van Boven JF, Beeh KM, Kostikas K, Roche N, Usmani OA, Mastoridis P
Pragmatic and Observational Research 2021, 12:25-35
Published Date: 24 May 2021
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
van Weissenbruch R, Klimek L, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, Kuhl HC, Pohl W, Scadding GK, Price D, Mullol J
Journal of Asthma and Allergy 2020, 13:633-645
Published Date: 2 December 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3093-3103
Published Date: 26 November 2020
Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study
Voorham J, Baldi S, Santoro L, Kerkhof M, Contoli M, Fabbri LM, Kerstjens HAM, Luis López-Campos J, Roche N, Singh D, Vogelmeier CF, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2739-2750
Published Date: 29 October 2020
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum]
Kostikas K, Price D, Gutzwiller FS, Jones B, Loefroth E, Clemens A, Fogel R, Jones R, Cao H
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2559-2560
Published Date: 16 October 2020
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients
Kritikos V, Price D, Papi A, Infantino A, Ställberg B, Ryan D, Lavorini F, Chrystyn H, Haughney J, Lisspers K, Gruffydd-Jones K, Román Rodríguez M, Høegh Henrichsen S, van der Molen T, Carter V, Bosnic-Anticevich S
Journal of Asthma and Allergy 2020, 13:415-428
Published Date: 6 October 2020
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JWH, Sadatsafavi M, Sin DD, Carter V, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1909-1918
Published Date: 6 August 2020
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database
Kostikas K, Price D, Gutzwiller FS, Jones B, Loefroth E, Clemens A, Fogel R, Jones R, Cao H
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1729-1738
Published Date: 16 July 2020
Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study
Kostikas K, Rhee CK, Hurst JR, Agostoni P, Cao H, Fogel R, Jones R, Kocks JWH, Mezzi K, Wan Yau Ming S, Ryan R, Price DB
Pragmatic and Observational Research 2020, 11:55-66
Published Date: 2 June 2020
Treatment Adherence in Adolescents with Asthma
Kaplan A, Price D
Journal of Asthma and Allergy 2020, 13:39-49
Published Date: 14 January 2020
Management Of Community-Acquired Pneumonia: An Observational Study In UK Primary Care
Launders N, Ryan D, Winchester CC, Skinner D, Konduru PR, Price DB
Pragmatic and Observational Research 2019, 10:53-65
Published Date: 23 September 2019
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]
Bosnic-Anticevich S, Chrystyn H, Costello R, Dolovich MB, Fletcher M, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1739-1740
Published Date: 2 August 2019
Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study
Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1595-1601
Published Date: 25 July 2019
Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation
Price DB, Yang S, Wan Yau Ming S, Hardjojo A, Cabrera C, Papaioannou AI, Loukides S, Kritikos V, Bosnic-Anticevich SZ, Carter V, Dorinsky PM
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3937-3946
Published Date: 13 December 2018
Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks
Grigg J, Nibber A, Paton JY, Chisholm A, Guilbert TW, Kaplan A, Turner S, Roche N, Hillyer EV, Price DB
Journal of Asthma and Allergy 2018, 11:309-321
Published Date: 11 December 2018
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
Price DB, Trudo F, Voorham J, Xu X, Kerkhof M, Ling Zhi Jie J, Tran TN
Journal of Asthma and Allergy 2018, 11:193-204
Published Date: 29 August 2018
Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory disease
Price DB, Smith PK, Harvey RJ, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS
Pragmatic and Observational Research 2018, 9:43-54
Published Date: 15 August 2018
Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2471-2472
Published Date: 15 August 2018
Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data
Colice G, Chisholm A, Dima AL, Reddel HK, Burden A, Martin RJ, Brusselle G, Popov TA, von Ziegenweidt J, Price DB
Pragmatic and Observational Research 2018, 9:29-42
Published Date: 10 August 2018
Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey [Erratum]
Price D, Keininger DL, Viswanad B, Gasser M, Walda S, Gutzwiller FS
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2253-2254
Published Date: 25 July 2018
Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey
Price D, Keininger DL, Viswanad B, Gasser M, Walda S, Gutzwiller FS
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:695-702
Published Date: 26 February 2018
The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship
Colice G, Price D, Gerhardsson de Verdier M, Rabon-Stith K, Ambrose C, Cappell K, Irwin DE, Juneau P, Vlahiotis A
Pragmatic and Observational Research 2017, 8:231-240
Published Date: 1 December 2017
Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study
Carney AS, Price DB, Smith PK, Harvey R, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner DA, Carter V, Durieux AMS
Pragmatic and Observational Research 2017, 8:157-165
Published Date: 30 August 2017
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
Jones R, Martin J, Thomas V, Skinner D, Marshall J, Stagno d'Alcontres M, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2445-2454
Published Date: 17 August 2017
Asthma referrals: a key component of asthma management that needs to be addressed
Price D, Bjermer L, Bergin DA, Martinez R
Journal of Asthma and Allergy 2017, 10:209-223
Published Date: 25 July 2017
Effective deployment of technology-supported management of chronic respiratory conditions: a call for stakeholder engagement
Costello RW, Dima AL, Ryan D, McIvor RA, Boycott K, Chisholm A, Price D, Blakey JD
Pragmatic and Observational Research 2017, 8:119-128
Published Date: 5 July 2017
Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database
Price DB, Gefen E, Gopalan G, Miglio C, McDonald R, Thomas V, Wan Yau Ming S
Pragmatic and Observational Research 2017, 8:69-83
Published Date: 18 May 2017
Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases
Smith P, Price D, Harvey R, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS
Journal of Asthma and Allergy 2017, 10:153-161
Published Date: 9 May 2017
Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study
Dollerup J, Vestbo J, Murray-Thomas T, Kaplan A, Martin RJ, Pizzichini E, Pizzichini MMM, Burden A, Martin J, Price DB
Clinical Epidemiology 2017, 9:231-243
Published Date: 26 April 2017
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study
Voorham J, Vrijens B, van Boven JFM, Ryan D, Miravitlles M, Law LM, Price DB
Pragmatic and Observational Research 2017, 8:31-41
Published Date: 18 April 2017
An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
Burden A, Roche N, Miglio C, Hillyer EV, Postma DS, Herings RMC, Overbeek JA, Khalid JM, van Eickels D, Price DB
Pragmatic and Observational Research 2017, 8:15-30
Published Date: 22 March 2017
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:907-922
Published Date: 17 March 2017
Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
Price D, Østrem A, Thomas M, Welte T
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:141-168
Published Date: 30 December 2016
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes
Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:59-71
Published Date: 21 December 2016
Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease
Price DB, Rigazio A, Buatti Small M, Ferro TJ
Journal of Asthma and Allergy 2016, 9:145-154
Published Date: 26 August 2016
Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database
Lee H, Rhee CK, Lee BJ, Choi DC, Kim JA, Kim SH, Jeong Y, Kim TH, Chon GR, Jung KS, Lee SH, Price D, Yoo KH, Park HY
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:775-783
Published Date: 15 April 2016
Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C
Journal of Asthma and Allergy 2016, 9:1-12
Published Date: 7 January 2016
Predicting frequent COPD exacerbations using primary care data
Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2439-2450
Published Date: 9 November 2015
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2207-2217
Published Date: 15 October 2015
Time for a new language for asthma control: results from REALISE Asia
Price D, David-Wang A, Cho SH, Ho JCM, Jeong JW, Liam CK, Lin JT, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G
Journal of Asthma and Allergy 2015, 8:93-103
Published Date: 23 September 2015
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:549-564
Published Date: 16 March 2015
Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C, Thomas M
Journal of Asthma and Allergy 2015, 8:1-13
Published Date: 14 January 2015
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WMC, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1163-1186
Published Date: 17 October 2014
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:889-905
Published Date: 27 August 2014
Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
Brockwell C, Ampikaipakan S, Sexton DW, Price D, Freeman D, Thomas M, Ali M, Wilson AM
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:715-721
Published Date: 9 July 2014
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification
Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:551-561
Published Date: 28 May 2014
Switching patients from other inhaled corticosteroid devices to the Easyhaler®: historical, matched-cohort study of real-life asthma patients
Price D, Thomas V, von Ziegenweidt J, Gould S, Hutton C, King C
Journal of Asthma and Allergy 2014, 7:31-51
Published Date: 10 April 2014
Impact of night-time symptoms in COPD: a real-world study in five European countries
Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:595-603
Published Date: 27 November 2013
The challenge of recruiting in primary care for a trial of telemonitoring in asthma: an observational study
Malhotra S, Musgrave SD, Pinnock H, Price D, Ryan DP
Pragmatic and Observational Research 2012, 3:51-55
Published Date: 24 August 2012
Physicians’ attitudes towards combination therapy with inhaled corticosteroids and long-acting ß2-agonists: an observational study in UK specialist care
Thomas M, Haughney J, Price D
Pragmatic and Observational Research 2011, 2:25-31
Published Date: 16 December 2011
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease
Jones PW, Price D, van der Molen T
International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:289-296
Published Date: 26 May 2011
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N
Journal of Asthma and Allergy 2011, 4:37-47
Published Date: 28 April 2011
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
Linda Kemp, John Haughney, Neil Barnes, et al
ClinicoEconomics and Outcomes Research 2010, 2:75-85
Published Date: 1 July 2010